December 16, 2022 | Deborah Kotz
Contact
Deborah Kotz
Senior Director of Media Relations
Office of Public Affairs & Communications
University of Maryland School of Medicine
Email: DKotz@som.umaryland.edu
o: 410-706-4255
c: 410-804-0054
t: @debkotz2
Related stories
Wednesday, January 31, 2024
Renowned Surgeon Dr. Bartley Griffith Named Vice Chair for Innovation in UM School of Medicine’s Department of Surgery
University of Maryland School of Medicine (UMSOM) Department of Surgery Chair Christine Lau, MD, MBA, along with UMSOM Dean Mark T. Gladwin, MD, announced today the appointment of Bartley P. Griffith, MD, as the Department of Surgery’s first Vice Chair for Innovation. In this role, Dr. Griffith will nurture a culture of innovation, entrepreneurship, and collaboration in the Department, and expand the integration of related sciences into surgical practice. The appointment is effective on February 1.
Tuesday, October 31, 2023
In Memoriam: Lawrence Faucette
It is with great sadness that we announce the passing of Lawrence Faucette, the 58-year-old patient with terminal heart disease who received the world’s second genetically-modified pig heart transplant. Mr. Faucette received the transplant on September 20 and lived for nearly six weeks following the surgery.
Friday, September 22, 2023
UM Medicine Faculty-Scientists and Clinicians Perform Second Historic Transplant of Pig Heart into Patient with End-Stage Cardiovascular Disease
A 58-year-old patient with terminal heart disease became the second patient in the world to receive a historic transplant of a genetically-modified pig heart on September 20. He is recovering and communicating with his loved ones. This is only the second time in the world that a genetically modified pig heart has been transplanted into a living patient. Both historic surgeries were performed by University of Maryland School of Medicine (UMSOM) faculty at the University of Maryland Medical Center (UMMC).
Friday, June 30, 2023
Lessons Learned from World’s First Successful Transplant of Genetically-Modified Pig Heart into Human Patient
A new study published today in the Lancet has revealed the most extensive analysis to date on what led to the eventual heart failure in the world's first successful transplant of a genetically-modified pig heart into a human patient. This groundbreaking procedure was conducted by University of Maryland School of Medicine (UMSOM) physician-scientists back in January 2022 and marked an important milestone for medical science.
Monday, November 14, 2022
Unexpected Electrical Changes Seen in First Successful Transplant of Genetically-Modified Pig Heart
Ten months after transplanting the first genetically-modified pig heart into a human patient, University of Maryland School of Medicine (UMSOM) researchers continue to report on new findings from the landmark transplant. Their latest study demonstrates for the first time that unexpected electrical changes occurred in the pig heart transplanted into the patient David Bennett. The findings were presented at the American Heart Association (AHA) meeting this past weekend.
Wednesday, June 22, 2022
University of Maryland School of Medicine Faculty Scientists and Clinicians Publish Findings of World’s First Successful Transplant of Genetically Modified Pig Heart into Human Patient
Six months ago, University of Maryland School of Medicine surgeon-scientists successfully implanted a genetically modified pig heart into a 57 year-old patient with terminal heart disease in a first-of-its-kind surgery. It was considered an early success because the patient lived for two months with a strong functioning heart showing no obvious signs of rejection, according to a new paper published today in the New England Journal of Medicine.